Hosted on MSN25d
Penumbra, Inc. (PEN): Innovating in Thrombectomy and Embolization with New FDA-Approved Technologies
Penumbra, Inc. (NYSE ... another solid double digit performance in stroke thrombectomy. As interest wanes in the Super Large Bore OE8 catheters as aspiration catheters, most of the companies ...
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
Oppenheimer predicts growth for Penumbra Inc in MT market. Analyst initiates coverage with Outperform rating and $275 target ...
Penumbra initiated with an Outperform at Oppenheimer
Oppenheimer initiated coverage of Penumbra (PEN) with an Outperform rating and $275 price target Penumbra is a leader in the mechanical ...
Investing1mon
Penumbra reports shorter stays, fewer PE complications with CAVT
Penumbra, Inc. (NYSE ... reported compared to other methods like anticoagulation, catheter-directed thrombolysis, or mechanical thrombectomy devices. Dr. Parag J. Patel, an interventional ...
Medscape2y
Neuroimaging of Ischemic Stroke With CT and MRI: Advancing Towards Physiology-Based Diagnosis and Therapy
Several additional trials are using identification of a penumbra by neuroimaging for ... safety and treatment feasibility of the NeuroFlo Catheter in late-presenting acute ischemic stroke patients ...